Timing for Bone Marrow Mononuclear Cells After Acute Myocardial Infarction
Myocardial Infarction
About this trial
This is an interventional treatment trial for Myocardial Infarction focused on measuring cell therapy, BMC, timing
Eligibility Criteria
Inclusion Criteria:
- a history of first acute ST-elevation myocardial infarction
- treatment with successful PCI two to twelve hours after symptom onset
- LVEF less than 50% on angiography immediately after emergency PCI or rescue PCI
Exclusion Criteria:
- previous Q-wave myocardial infarction
- cardiogenic shock
- severe coexisting conditions such as acute and chronic heart failure, malignant
- arrhythmia, renal failure and severe bleeding that interfered with the ability of the
- patient to comply with the protocol
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Active Comparator
BMC therapy within 24 hours
BMC therapy within 3-7 days
BMC therapy within 7-30 days
PCI only
Patients with acute myocardial infarction who receive intracoronary infusion of BMC within 24 hours after successful primary PCI.
Patients with acute myocardial infarction who receive intracoronary infusion of BMC within 3-7days after successful primary PCI.
Patients with acute myocardial infarction who receive intracoronary infusion of BMC within 7-30days after successful primary PCI.
Patients with acute myocardial infarction who were performed successful primary PCI.